Complex Partial Seizures
📧 Sign up to get email alerts when something new happens for Complex Partial Seizures.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2026-03-18FDA Approved: SABRIL — Supplemental Application (Lundbeck Pharmaceuticals LLC)
The FDA approved a supplemental application for Sabril (vigabatrin) submitted by Lundbeck Pharmaceuticals LLC.
-
FDA approval · 2026-03-18FDA Approved: VIGABATRIN — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for Vigabatrin submitted by Zydus Lifesciences Limited. This action constitutes a supplemental appro…
-
FDA approval · 2026-03-18FDA Approved: VIGABATRIN — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Vigabatrin submitted by Aurobindo Pharma Limited.
-
FDA approval · 2026-03-18FDA Approved: VIGABATRIN — Supplemental Application (Zydus Pharmaceuticals (USA) Inc.)
FDA approved a supplemental application for Vigabatrin submitted by Zydus Pharmaceuticals (USA) Inc. The approval confirms the supplemental …
-
FDA approval · 2024-09-12FDA Approved: SABRIL — Supplemental Application (Lundbeck Pharmaceuticals LLC)
FDA approved a supplemental application for Sabril (vigabatrin) submitted by Lundbeck Pharmaceuticals LLC. The approval updates the product …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-09-12FDA Approved: VIGADRONE — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved a supplemental application for VIGADRONE (vigabatrin) by Upsher-Smith Laboratories, LLC under ANDA 210196.
-
FDA approval · 2024-09-12FDA Approved: VIGABATRIN FOR ORAL SOLUTION — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application to Camber Pharmaceuticals for Vigabatrin for oral solution, enabling a generic oral form of Vigabatr…
-
FDA approval · 2024-06-17FDA Approved: VIGAFYDE — Original Application (Upsher-Smith Laboratories, LLC)
FDA approves VIGAFYDE (vigabatrin) from Upsher-Smith in an original NDA; the product is indicated for certain seizure disorders, including i…
-
FDA approval · 2023-06-29FDA Approved: VIGADRONE — Original Application (Upsher-Smith Laboratories, LLC)
The FDA approved Upsher-Smith Laboratories' original application for Vigadrone (vigabatrin), a generic form of the anticonvulsant vigabatrin…
-
FDA approval · 2023-03-02FDA Approved: VIGABATRIN — Original Application (Zydus Lifesciences Limited)
FDA approves Zydus Lifesciences Limited's original ANDA for Vigabatrin, allowing a generic version of the anti-epileptic drug. The approval …
-
FDA approval · 2022-11-08FDA Approved: VIGABATRIN — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved a supplemental application for Vigabatrin from Amneal Pharmaceuticals NY LLC, enabling a generic version of the drug.
-
FDA approval · 2022-10-26FDA Approved: VIGABATRIN — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved a supplemental application for Vigabatrin submitted by Ascend Laboratories, LLC.
-
FDA approval · 2022-10-12FDA Approved: SABRIL — Supplemental Application (Lundbeck Pharmaceuticals LLC)
FDA approves a supplemental application for Sabril (vigabatrin) submitted by Lundbeck Pharmaceuticals LLC.
-
FDA approval · 2022-10-12FDA Approved: VIGABATRIN — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Vigabatrin submitted by Actavis Pharma, Inc. under ANDA 209822.
-
FDA approval · 2022-10-12FDA Approved: VIGABATRIN — Supplemental Application (Dr. Reddys Laboratories Inc.,)
FDA approved a supplemental application for Vigabatrin from Dr. Reddy's Laboratories, indicating an approved modification to the original AN…
-
FDA approval · 2022-10-12FDA Approved: VIGABATRIN — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for Vigabatrin submitted by Ascend Laboratories, LLC.
-
FDA approval · 2022-10-12FDA Approved: VIGABATRIN — Supplemental Application (Novadoz Pharmaceuticals LLC)
FDA approved a supplemental application for vigabatrin filed by Novadoz Pharmaceuticals LLC.
-
FDA approval · 2022-10-12FDA Approved: VIGABATRIN — Supplemental Application (Edenbridge Pharmaceuticals LLC.)
FDA approved a supplemental application for Vigabatrin from Edenbridge Pharmaceuticals LLC. under ANDA 215109.
-
FDA approval · 2022-06-22FDA Approved: VIGABATRIN — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approves the original ANDA for Vigabatrin (Amneal Pharmaceuticals NY LLC) for the treatment of infantile spasms and refractory complex p…
-
FDA approval · 2021-10-20FDA Approved: SABRIL — Supplemental Application (Lundbeck Pharmaceuticals LLC)
FDA approved a supplemental application for Sabril (vigabatrin) by Lundbeck Pharmaceuticals LLC.
-
FDA approval · 2021-01-26FDA Approved: VIGABATRIN — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Vigabatrin from Actavis Pharma, Inc., indicating an approval action related to an update to the …
-
FDA approval · 2020-10-02FDA Approved: VIGABATRIN — Supplemental Application (Dr. Reddys Laboratories Inc.,)
FDA granted a supplemental approval for Vigabatrin by Dr. Reddys Laboratories Inc., initiating a new regulatory action related to the produc…
-
FDA approval · 2020-10-02FDA Approved: VIGADRONE — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved a supplemental application for Vigadrone (vigabatrin) from Upsher-Smith Laboratories, LLC. This action authorizes changes r…
-
FDA approval · 2019-09-12FDA Approved: VIGABATRIN — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved a supplemental application for Vigabatrin from Amneal Pharmaceuticals NY LLC.
-
FDA approval · 2019-09-12FDA Approved: VIGABATRIN — Supplemental Application (Actavis Pharma, Inc.)
FDA approved Actavis Pharma's supplemental application for Vigabatrin, updating the existing approval for the drug.